Skip to menu Skip to content Skip to footer

2014

Journal Article

Nanocell targeting using engineered bispecific antibodies.

Taylor, Karin, Howard, Christopher B., Jones, Martina L., Sedliarou, Ilya, MacDiarmid, Jennifer, Brahmbhatt, Himanshu, Munro, Trent P. and Mahler, Stephen M. (2014). Nanocell targeting using engineered bispecific antibodies.. mAbs, 7 (1), 53-65. doi: 10.4161/19420862.2014.985952

Nanocell targeting using engineered bispecific antibodies.

2014

Journal Article

Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy - future prospects

Goodall, Stephen, Jones, Martina L. and Mahler, Stephen (2014). Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy - future prospects. Journal of Chemical Technology and Biotechnology, 90 (7), 1169-1176. doi: 10.1002/jctb.4555

Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy - future prospects

2014

Journal Article

Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells

Buecheler, Jakob W., Howard, Christopher B., de Bakker, Christopher J., Goodall, Stephen, Jones, Martina L, Win, Thinzar, Peng, Tao, Tan, Cher Heng, Chopra, Akhil, Mahler, Stephen M and Lim, Sierin (2014). Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells. Journal of Chemical Technology and Biotechnology, 90 (7), 1230-1236. doi: 10.1002/jctb.4545

Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells

2014

Journal Article

An EGFR targeting nanoparticle self assembled from a thermoresponsive polymer

Goodall, Stephen, Howard, Christopher B., Jones, Martina L., Munro,Trent, Jia, Zhongfan, Monteiro, Michael J and Mahler, Stephen (2014). An EGFR targeting nanoparticle self assembled from a thermoresponsive polymer. Journal of Chemical Technology and Biotechnology, 90 (7), 1222-1229. doi: 10.1002/jctb.4509

An EGFR targeting nanoparticle self assembled from a thermoresponsive polymer

2014

Journal Article

Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2

Leow, Chiuan Herng, Jones, Martina, Cheng, Qin, Mahler, Strphen and McCarthy, James (2014). Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2. Malaria Journal, 13 (1) 277. doi: 10.1186/1475-2875-13-277

Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2

2014

Conference Publication

The Monoclonal Antibody 3C12C, Targeting CD83 Is a T Cell Sparing, Potential New Immunosuppressive Agent

Hart, D, Verma, N., Seldon, T, Sheng, Y., Pryor, R., Palkova, A., Findova, M., Jones, M., Munro, T., Mahler, S., Braet, K., Barnard, R., Marks, J., Coley, A., Fan, F., Zhou, Y., Vu, P, Lo, K., Shahin, K., Elgundi, Z., Silveira, P., Fromm, P., Clark, G., Larsen, S., Bradstock, K. and Munster, D. (2014). The Monoclonal Antibody 3C12C, Targeting CD83 Is a T Cell Sparing, Potential New Immunosuppressive Agent. 2014 World Transplant Congress, San Francicso Ca, 26 - 31 July 2014. Malden, MA United States: Wiley-Blackwell Publishing, Inc.. doi: 10.1111/ajt.12888

The Monoclonal Antibody 3C12C, Targeting CD83 Is a T Cell Sparing, Potential New Immunosuppressive Agent

2013

Other Outputs

Anti-CD83 antibodies and use thereof

Seldon, T. A., Munster, D. J., Hart, D. N., Jones, M. L., Munro, T. P., Mahler, S. M., Zhou, Y. and Marks, D. (2013). Anti-CD83 antibodies and use thereof.

Anti-CD83 antibodies and use thereof

2011

Journal Article

Clonal selection of high producing, stably transfected HEK293 cell lines utilizing modified, high-throughput FACS screening

Song, Michael, Raphaelli, Kristin, Jones, Martina L., Aliabadi-Zadeh, Khosrow, Leung, Kar Man, Crowley, David, Hughes, Benjamin, Mahler, Stephen, Gray, Peter P., Huang, Edwin P. and Chin, David Y. (2011). Clonal selection of high producing, stably transfected HEK293 cell lines utilizing modified, high-throughput FACS screening. Journal of Chemical Technology and Biotechnology, 86 (7), 935-941. doi: 10.1002/jctb.2618

Clonal selection of high producing, stably transfected HEK293 cell lines utilizing modified, high-throughput FACS screening

2011

Journal Article

Improved protein-A separation of Vh3 Fab from Fc after papain digestion of antibodies

Seldon, Therese A., Hughes, Karen E., Munster, David J., Chin, David Y. and Jones, Martina L. (2011). Improved protein-A separation of Vh3 Fab from Fc after papain digestion of antibodies. Journal of Biomolecular Techniques, 22 (2), 50-52.

Improved protein-A separation of Vh3 Fab from Fc after papain digestion of antibodies

2010

Journal Article

A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies

Jones, Martina L., Seldon, Therese, Smede, Matthew, Linville, Ashleigh, Chin, David Y., Barnard, Ross, Mahler, Stephen M., Munster, David, Hart, Derek, Gray, Peter P. and Munro, Trent P. (2010). A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies. Journal of Immunological Methods, 354 (1-2), 85-90. doi: 10.1016/j.jim.2010.02.001

A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies

2009

Conference Publication

Developing a Therapeutic Anti - Dendritic Cell Antibody to Prevent Graft Versus Host Disease

Hart, D, Seldon, T, Jones, M, Sheng, Y, Palkova, A, Cullup, H, Munro, T, Sinfield, L, Rice, AM, Wilson, J, Gray, P, Barnard, R, Mahler, S and Munster, D (2009). Developing a Therapeutic Anti - Dendritic Cell Antibody to Prevent Graft Versus Host Disease. 51st Annual Meeting of the American Society of Hematology, New Orleans LA, 5-8 December 2009. Washington, D.C.: American Society of Hematology.

Developing a Therapeutic Anti - Dendritic Cell Antibody to Prevent Graft Versus Host Disease

2008

Other Outputs

Engineered antibodies. Production and application of chimeric and single-chain antibodies as positive controls in the diagnosis of infectious diseases by ELISA.

Jones, Martina (2008). Engineered antibodies. Production and application of chimeric and single-chain antibodies as positive controls in the diagnosis of infectious diseases by ELISA.. PhD Thesis, School of Molecular and Microbial Sciences, The University of Queensland. doi: 10.14264/156737

Engineered antibodies. Production and application of chimeric and single-chain antibodies as positive controls in the diagnosis of infectious diseases by ELISA.

2007

Journal Article

Use of chimeric antibodies as positive controls in an enzyme-linked immunosorbent assay for diagnosis of scrub typhus (infection by orientia tsutsugamushi)

Jones, Martina L. and Barnard, Ross (2007). Use of chimeric antibodies as positive controls in an enzyme-linked immunosorbent assay for diagnosis of scrub typhus (infection by orientia tsutsugamushi). Clinical and Vaccine Immunology, 14 (10), 1307-1310. doi: 10.1128/CVI.00114-07

Use of chimeric antibodies as positive controls in an enzyme-linked immunosorbent assay for diagnosis of scrub typhus (infection by orientia tsutsugamushi)

2005

Journal Article

Chimerization of multiple antibody classes using splice overlap extension PCR

Jones, M. L. and Barnard, R. T. (2005). Chimerization of multiple antibody classes using splice overlap extension PCR. Biotechniques, 38 (2), 181-182. doi: 10.2144/05382BM01

Chimerization of multiple antibody classes using splice overlap extension PCR

2003

Conference Publication

Dietary interactions influence the effects of bovine folate-binding protein on the bioavailability of tetrahydrofolates in rats

Jones, ML, Treloar, T and Nixon, PF (2003). Dietary interactions influence the effects of bovine folate-binding protein on the bioavailability of tetrahydrofolates in rats. USA: American Society for Nutritional Sciences. doi: 10.1093/jn/133.2.489

Dietary interactions influence the effects of bovine folate-binding protein on the bioavailability of tetrahydrofolates in rats

2002

Journal Article

Tetrahydrofolates are greatly stabilized by binding to bovine milk folate-binding protein

Jones, M. L. and Nixon, P. F. (2002). Tetrahydrofolates are greatly stabilized by binding to bovine milk folate-binding protein. Journal of Nutrition, 132 (9), 2690-2694. doi: 10.1093/jn/132.9.2690

Tetrahydrofolates are greatly stabilized by binding to bovine milk folate-binding protein

2001

Conference Publication

Availability of folate bound to folate-binding protein: Environmental effects

Jones, M. L., Treloar, W. and Nixon, P. F. (2001). Availability of folate bound to folate-binding protein: Environmental effects. 2nd Dairy Industry Association of Australia World Series of Dairy Science Conference, Australia, 2001. Melbourne: Dairy Industry Association of Australia.

Availability of folate bound to folate-binding protein: Environmental effects

2000

Conference Publication

Milk folate-binding protein; ligand-binding properties and polymerization properties

Jones, MD, Hutchinson, ML and Nixon, PF (2000). Milk folate-binding protein; ligand-binding properties and polymerization properties. Dairy Ingredient Science 2000 Conference, Melbourne, Australia, 2000. Melbourne,VIC: Dairy Industry Association of Australia.

Milk folate-binding protein; ligand-binding properties and polymerization properties

2000

Conference Publication

Stability of labile folate is enhanced by binding milk folate-binding protein

Hutchinson, M. L., Jones, M. and Nixon, P. F. (2000). Stability of labile folate is enhanced by binding milk folate-binding protein. Dairy Ingredient Science 2000 Conference, Melbourne, Australia, 28-30 Jun, 2000. Melbourne, Australia: Dairy Industry Association of Australia.

Stability of labile folate is enhanced by binding milk folate-binding protein